While the pandemic has impacted industries in different ways, clinical research has taken a tremendous leap forward in its evolution, rapidly embracing virtual solutions to keep forward progress going strong. For dermatology studies, one challenge has been determining how to use those virtual solutions for visual diagnostics and assessments in a way that is safe for all participants, but also effective, and ensures capturing proper efficacy assessments, study compliance and adherence to timelines.
By using top-rated vendors for adaptive protocol designs, simple and cost-effective photography documentation solutions, and employing visiting nurses to ensure standardization of images, dermatology trials can continue advancing in this new age of clinical trials.
On October 20th at 11:00 AM ET, join Synteract Dermatology team expert, Betsey Zbyszynski for a webinar on Leveraging Virtual Photography Solutions to Advance Dermatology Clinical Trials that explores the use of virtual imaging to safely and efficiently conduct dermatology studies.
Betsey Zbyszynski, Senior Director, Strategic Development, Dermatology, Synteract
Betsey Zbyszynski has been in the clinical research industry for over 25 years. She began her career as a clinical research coordinator at an ophthalmic clinical research site. Since then, Zbyszynski has worked in the clinical monitoring, project management and business development sectors of the industry. Zbyszynski was the Clinical Research Manager solely responsible for managing the clinical trials that received FDA approval of the first human collagen product for dermal filler.
For fifteen years, Zbyszynski worked in the CRO setting. She managed the growth of a start-up CRO division from $0 revenues to a $6 million revenue within its first year and was instrumental in the strategic partnership with a biometrics company. She helped managed another small start-up CRO to over $25 million in annual revenue by generating new business as well as maintaining the business relationships. Most recently, Zbyszynski worked on the pharma side as Director of Outsourcing. Her responsibilities included vendor management, RFPs and negotiating the clinical trial budgets and contracts. Her main therapeutic areas of expertise include dermatology, cosmetic dermatology and ophthalmology.Message Presenter
Doug Canfield, Founder & President, Canfield Scientific
Doug Canfield is the founder and President of Canfield Scientific, Inc., the global leader in imaging systems, services and products for scientific research and healthcare applications, including the pharmaceutical, biotechnology, cosmetics, medical and skin care industries. Canfield Scientific specializes in photographic documentation to help demonstrate drug efficacy in clinical drug trials worldwide. Mr. Canfield pioneered the use of specialized devices in medical photography and has developed a wide range of innovative solutions for research and practice. Mr. Canfield’s patented technology includes multi-spectral and multi-modal 2D and 3D image capture systems, digital asset management, aesthetic simulation, and applications for detection, measurement and analysis for various skin conditions. These technologies have contributed to the development of numerous treatments and procedures and has significantly advanced the use of optical imaging in both clinical research and practice. Mr. Canfield received his degree in Business Administration from Rutgers University, and is an Adjunct Clinical Professor of Medicine and Cardiology at Georgetown University School of Medicine.Message Presenter
Heather Haselmann, Director of Business Development, Canfield Scientific
Heather Haselmann has been with Canfield since 2005. She started as Project Manager for Clinical Services and grew to role of Associate Director of Clinical Services overseeing project teams which led her to current role as Director of Business Development in which she is able to speak to the team’s expertise. Haselmann is responsible for communicating the breadth and depth of clinical project management services, ensures customer service provided at the highest levels, including proposals and follow through of deliverables. Haselmann has extensive knowledge of the industry which covers Dermatology, from hair growth to onychomycosis, Aesthetics, Body Contouring, Oncology and Rare Diseases related to skin.Message Presenter
Who Should Attend?
This webinar will appeal to VPs, Directors, Managers, Department Heads, Scientists and Researchers working in dermatology drug development, in the areas of:
- Clinical Affairs
- Clinical R&D
- Clinical Research
- Clinical Pharmacology
- Clinical Operations
- Project Management
- Regulatory Affairs
- Medical Affairs
What You Will Learn
During the webinar, you will learn:
- Concepts such as adverse event photography, where patients can capture photos of a possible adverse reaction onset and rapidly share them with the study site for review and appropriate identification
- How to align simplicity with cost efficiencies by using compact photo documentation solutions
- How patients can securely submit images using their own device (agnostic platform), following guidelines to ensure standardization of the images for review
- How using Canfield’s web-based platform creates a seamless transfer of images from patient to site
With employees across 21 countries, Synteract is an innovative, full-service CRO supporting biopharma companies across all phases of drug development to help bring new medicines to market. Synteract has conducted 4,000 studies on six continents and in more than 60 countries, working with more than 26,000 investigative sites and 750,000 patients. Greater than 245 of its 4,000 studies have been in pediatric populations. In addition to pediatrics clinical trials, Synteract offers a notable depth of therapeutic expertise in dermatology, neurodegenerative, oncology and immunotherapy, and rare/orphan disease studies.